Van Damme P - Search Results

1

Pattyn J, Hendrickx G, Vorsters A, Van Damme P. Pattyn J, et al. Among authors: van damme p. J Infect Dis. 2021 Sep 30;224(12 Suppl 2):S343-S351. doi: 10.1093/infdis/jiaa668. J Infect Dis. 2021. PMID: 34590138 Free PMC article.

2

Hepatitis B control in Europe by universal vaccination programmes: the situation in 2001.

Van Damme P, Vorsters A. Van Damme P, et al. J Med Virol. 2002 Jul;67(3):433-9. doi: 10.1002/jmv.10091. J Med Virol. 2002. PMID: 12116040 Review.

3

Hepatitis B vaccination: how to reach risk groups.

François G, Hallauer J, Van Damme P. François G, et al. Among authors: van damme p. Vaccine. 2002 Nov 22;21(1-2):1-4. doi: 10.1016/s0264-410x(02)00440-1. Vaccine. 2002. PMID: 12443655

4

Long-term protection after hepatitis A and B vaccination: an update.

Van Damme P. Van Damme P. Acta Gastroenterol Belg. 2003 Jul-Sep;66(3):247-9. Acta Gastroenterol Belg. 2003. PMID: 14618958 No abstract available.

5

Five years follow-up following two or three doses of a hepatitis B vaccine in adolescents aged 11-15 years: a randomised controlled study.

Van Damme P, Moiseeva A, Marichev I, Kervyn AD, Booy R, Kuriyakose S, Brockway A, Ng SP, Leyssen M, Jacquet JM. Van Damme P, et al. BMC Infect Dis. 2010 Dec 20;10:357. doi: 10.1186/1471-2334-10-357. BMC Infect Dis. 2010. PMID: 21171982 Free PMC article. Clinical Trial.

6

Long-term immunogenicity and immune memory after two doses of the adult formulation of a combined hepatitis A and B vaccine in children 1 to 11 years of age.

van Damme P, Kafeja F, Van Der Wielen M, Leyssen M, Jacquet JM. van Damme P, et al. Among authors: van der wielen m. Pediatr Infect Dis J. 2011 Aug;30(8):703-5. doi: 10.1097/INF.0b013e3182138296. Pediatr Infect Dis J. 2011. PMID: 21346683

7

Hepatitis B and the need for a booster dose.

Leuridan E, Van Damme P. Leuridan E, et al. Among authors: van damme p. Clin Infect Dis. 2011 Jul 1;53(1):68-75. doi: 10.1093/cid/cir270. Clin Infect Dis. 2011. PMID: 21653306

8

Antibody persistence and immune memory in healthy adults following vaccination with a two-dose inactivated hepatitis A vaccine: long-term follow-up at 15 years.

Van Herck K, Jacquet JM, Van Damme P. Van Herck K, et al. Among authors: van damme p. J Med Virol. 2011 Nov;83(11):1885-91. doi: 10.1002/jmv.22200. Epub 2011 Aug 23. J Med Virol. 2011. PMID: 21915861

9

Seventeen-year antibody persistence in adults primed with two doses of an inactivated hepatitis A vaccine.

Van Herck K, Crasta PD, Messier M, Hardt K, Van Damme P. Van Herck K, et al. Among authors: van damme p. Hum Vaccin Immunother. 2012 Mar;8(3):323-7. doi: 10.4161/hv.18617. Epub 2012 Feb 13. Hum Vaccin Immunother. 2012. PMID: 22327499 Clinical Trial.

10

Two decades of hepatitis B vaccination in mentally retarded patients: effectiveness, antibody persistence and duration of immune memory.

Braeckman T, Van Herck K, Jilg W, Bauer T, Van Damme P. Braeckman T, et al. Among authors: van damme p, van herck k. Vaccine. 2012 Jul 6;30(32):4757-61. doi: 10.1016/j.vaccine.2012.05.044. Epub 2012 May 29. Vaccine. 2012. PMID: 22652400

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,225 results

Search Page